MEDICAL NEWS
IUD Won’t Interfere With Breast-Feeding
2:00 PM EST.
No reason to delay this type of birth control after having a baby
Read article
- Yoga May Bring Better Sleep to Breast Cancer Patients
- Gun Surrender Laws Help Women Threatened by Domestic Violence
- Focus on Just One Sport Can Mean Stress for Girls
- Higher Cigarette Taxes May Mean Fewer Infant Deaths
JOURNAL UPDATE
Effect of Osteoporotic Fractures Similar to Diabetes Burden
7:00 PM EST. Findings for quality of life with hip fractures, vertebral compression vs. vision loss, amputation- Few Older Patients Aware of Deprescribing
- Fasting Blood Glucose Trajectory May Predict Future MI
- Laser Tx Aids Genitourinary Symptoms of Menopause
MONTHLY JOURNAL SUMMARY
August 2017 Briefing - OBGYN & Women’s Health
September 01, 2017. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
BRCA mutation testing
By Tamer M. Fouad, M.D.The BRCA gene test is used to identify mutations in either one of the two breast cancer susceptibility genes, BRCA1 and BRCA2. Women who have inherited…
DISCUSSION
RE: Aspirin Use as Treatment in Colorectal Cancer: Teaching an Old Dog New Tricks
By Jeffrey A. Gordon, M.D.Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
ANNOUNCEMENTS
Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.
